A2 Milk Fortifies China Presence with Pokeno Acquisition and Strategic Brand Transition

By / / Breaking News

Key Takeaways

  • A2 Milk (A2M) has completed the acquisition of the Pokeno manufacturing facility for approximately NZ$282 million, a move central to its expanded China strategy.
  • The Pokeno facility includes two existing China label infant milk formula (IMF) product registrations, which A2 Milk (A2M) plans to transition to its own brand and relaunch within 12-18 months.
  • The company anticipates final SAMR approval for the transition of these two China label registrations by December 2025, marking a critical step for its market access.
  • This strategic acquisition, alongside the divestment of Mataura Valley Milk, is expected to enable A2 Milk (A2M) to return substantial value to shareholders through a planned NZ$300 million special dividend.

The a2 Milk Company (A2M) is significantly strengthening its foothold in the lucrative Chinese infant milk formula (IMF) market through the recent acquisition of the Pokeno manufacturing facility in New Zealand. This strategic move, completed around September 1, 2025, for approximately NZ$282 million, positions A2 Milk (A2M) for direct control over key production and regulatory assets. The facility was acquired from Yashili New Zealand Dairy, a subsidiary of China Mengniu Dairy Group.

Crucially, the Pokeno facility comes with two pre-existing China label IMF product registrations. A2 Milk (A2M) intends to apply for regulatory approval from China's State Administration for Market Regulation (SAMR) to amend these registrations for use under its own brand. This transition will involve reformulating the products to be A1 protein-free, with a relaunch targeted within 12 to 18 months following the acquisition. The company expects final SAMR approval for this brand transition by December 2025.

This initiative is a cornerstone of A2 Milk's (A2M) refreshed growth strategy, aiming to tap into the China label IMF market, which constitutes approximately 81% of the total Chinese IMF market. While A2 Milk (A2M) already secured SAMR re-registration for its Synlait-produced China label IMF product (至初®) in June 2023, valid until September 2027, the Pokeno acquisition provides additional, direct control over manufacturing and registrations. The company is also actively pursuing access to a potential third registration slot.

The acquisition also underscores A2 Milk's (A2M) commitment to optimizing its supply chain and delivering shareholder value. Alongside the divestment of its 75% stake in Mataura Valley Milk for NZ$100 million, the company plans to pay a NZ$300 million special dividend to shareholders, contingent on regulatory approvals for the Pokeno acquisition and the completion of the divestment. Furthermore, A2 Milk (A2M) plans to invest an additional NZ$100 million in the Pokeno plant to boost capacity and capabilities, expecting to create over 100 new jobs over time.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top